UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Implications of NRAS mutations in AML: a study of 2502 patients

Blood, 2006-05, Vol.107 (10), p.3847-3853

2006

Link zum Volltext

Verfügbarkeit prüfen

Acute Myeloid Leukemias with Reciprocal Rearrangements Can Be Distinguished by Specific Gene Expression Profiles

Proceedings of the National Academy of Sciences - PNAS, 2002-07, Vol.99 (15), p.10008-10013

2002

Link zum Volltext

Verfügbarkeit prüfen

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Blood, 2003-01, Vol.101 (1), p.64-70

2003

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Tool for the Identification of MLL Rearrangements Including Unknown Partner Genes

Proceedings of the National Academy of Sciences - PNAS, 2005-01, Vol.102 (2), p.449-454

2005

Link zum Volltext

Verfügbarkeit prüfen

6-Thioguanine, Cytarabine, and Daunorubicin (TAD) and High-Dose Cytarabine and Mitoxantrone (HAM) for Induction, TAD for Consolidation, and Either Prolonged Maintenance by Reduced Monthly TAD or TAD-HAM-TAD and One Course of Intensive Consolidation by Sequential HAM in Adult Patients at All Ages With De Novo Acute Myeloid Leukemia (AML): A Randomized Trial of the German AML Cooperative Group

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4496-4504

2003

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of minimal residual disease in acute myeloid leukemia

Critical reviews in oncology/hematology, 2005-11, Vol.56 (2), p.283-309

2005

Link zum Volltext

Verfügbarkeit prüfen

Management of Acute Myeloid Leukemia in Elderly Patients

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3569-3576

1999

Link zum Volltext

Verfügbarkeit prüfen

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

Journal of clinical oncology, 2003-01, Vol.21 (2), p.256-265

2003

Link zum Volltext

Verfügbarkeit prüfen

A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia

Blood, 2002-11, Vol.100 (9), p.3423-3425

2002

Link zum Volltext

Verfügbarkeit prüfen

Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia

Haematologica (Roma), 2007-04, Vol.92 (4), p.542-545

2007

Link zum Volltext

Verfügbarkeit prüfen

Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression

Blood, 2006-11, Vol.108 (9), p.3152-3160

2006

Link zum Volltext

Verfügbarkeit prüfen

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

Blood, 2005-12, Vol.106 (12), p.3733-3739

2005

Link zum Volltext

Verfügbarkeit prüfen

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Blood, 2006-03, Vol.107 (5), p.1791-1799

2006

Link zum Volltext

Verfügbarkeit prüfen

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

Leukemia, 2004, Vol.18 (1), p.120-125

2004

Link zum Volltext

Verfügbarkeit prüfen

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

Blood, 2004-11, Vol.104 (10), p.3078-3085

2004

Link zum Volltext

Verfügbarkeit prüfen

AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

Blood, 2003-10, Vol.102 (7), p.2395-2402

2003

Link zum Volltext

Verfügbarkeit prüfen

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

Blood, 2002-07, Vol.100 (1), p.59-66

2002

Link zum Volltext

Verfügbarkeit prüfen

Global approach to the diagnosis of leukemia using gene expression profiling

Blood, 2005-08, Vol.106 (4), p.1189-1198

2005

Link zum Volltext

Verfügbarkeit prüfen

Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease

American journal of human genetics, 2006-02, Vol.78 (2), p.279-290

2006

Link zum Volltext

Verfügbarkeit prüfen

New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFB-MYH11+ acute myeloid leukemia based on quantification of fusion transcripts

Blood, 2003-10, Vol.102 (8), p.2746-2755

2003

Link zum Volltext

Verfügbarkeit prüfen

Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile

Genes chromosomes & cancer, 2005-07, Vol.43 (3), p.227-238

2005

Link zum Volltext

Verfügbarkeit prüfen

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up

Cancer, 2005-04, Vol.103 (8), p.1659-1669

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(214)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(123)
Science & Technology
(116)
Life Sciences & Biomedicine
(112)
Middle Aged
(74)
Adult
(68)
Biological And Medical Sciences
(68)
Aged
(67)
Medical Sciences
(67)
Hematology
(65)
Male
(64)
Female
(59)
Hematologic And Hematopoietic Diseases
(55)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(53)
Oncology
(45)
Aged, 80 And Over
(39)
Acute Disease
(38)
Prognosis
(36)
Chromosome Aberrations
(35)
Adolescent
(33)
Karyotyping
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Implications of NRAS mutations in AML: a study of 2502 patients

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia

Acute Myeloid Leukemias with Reciprocal Rearrangements Can Be Distinguished by Specific Gene Expression Profiles

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Diagnostic Tool for the Identification of MLL Rearrangements Including Unknown Partner Genes

MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene

Monitoring of minimal residual disease in acute myeloid leukemia

Management of Acute Myeloid Leukemia in Elderly Patients

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia

Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia

Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

Global approach to the diagnosis of leukemia using gene expression profiling

Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease

New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFB-MYH11+ acute myeloid leukemia based on quantification of fusion transcripts

Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up

Suchergebnisse filtern